Fibrocell Science (FCSC) Misses Q2 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. HUBS
2. FIS
3. ARM
4. BROS
5. QCOM
6. EXPE
7. PAYC
8. APP
9. FSLY
10. CPAY

Go back to Fibrocell Science (FCSC) Misses Q2 EPS by 1c

Fibrocell Science Reports Second Quarter 2015 Financial Results and Operational Highlights

August 6, 2015 8:05 AM EDT

EXTON, Pa., Aug. 6, 2015 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC), an autologous cell and gene therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today reported financial results for the quarter ended June 30, 2015 and recent operational highlights. Fibrocell will host a conference call and webcast today at 8:30 a.m. EDT.

"We've made significant progress advancing our pipeline," said David Pernock, Chairman and Chief Executive Officer of Fibrocell. "Submission of an IND application for FCX-007our lead orphan gene-therapy product candidate for the... More